Key points from this week’s report:
Please refer to the attached PDF for the full report.
- European indices staged a v-shaped recovery, maintaining its upward momentum following a sharp decline in early August. Belgium, Germany and Switzerland clocked fresh 52-week highs and thus, were moved recently to a Confirmed Uptrend. The U.K., Spain, Finland, Austria, Italy, Sweden, and Norway are trading 1–2% off 52-week highs. All indices except France are now trading above 50- and 200-DMA. France’s CAC also made a strong recovery, retaking its 50-DMA but the index is still trading below its 200-DMA, 8% off 52-week highs.
- We recommend adding risks as the indices continue to remain constructive above key moving averages and nearing 52-week highs. Focus on quality ideas with good O’Neil quantitative metrics and strong industry groups emerging out from proper bases or bouncing off key support levels.
- Sectors closed positive last week except Energy (-0.1%) and Retail (-0.1%). Health Care, Staples, Utility, Capital Equipment, Basic Material, and Financial closed 1–2% higher. Technology was up 0.6% while Cyclicals closed flat. On our rotation graph, Health Care, Financial, and Retail remained in the best quadrant, exhibiting positive momentum. Staple, Utility, and Transportation also showed positive short-term momentum. Technology, Cyclicals, Materials, and Energy showed negative short-term momentum and remained in the worst quadrant.
- Market breadth continued to improve last week reflected by the rising number of stocks basing, forming the right side of a consolidation on improving technical or breaking out of consolidation (refer from Sector Score Cards from page 9 to 20). Stocks of interests include: Oci (OCIO.NL), Elis (ELIS.FR), Lifco (LIFC.SE), Novartis (NOVN.CH), Pandora (PND.DK), and Auto Trader (AUTO.GB).
- From our Focus List, actionable ideas include Biotage (BIOT.SE), Inditex (IND.ES), Lonza Group (LONN.CH), Premier Foods (PFD.GB), Nkt (NKT.DK), Relx (REL.GB), Swedish Orphan Biovitrum (SOBI.SE), 3i Group (III.GB), Galderma (GALD.CH), and recent addition Novozymes (NZY.DK).